Salesforce shares sit at the epicenter of AI confusion. Here's how to trade it

Salesforce shares remain choppy after rising more than 22% following August Q2 results that beat expectations; the stock is now near $230 and down nearly 10% year to date as investors weigh strong financials against AI disruption concerns. The contributor describes a Nov. 20 short iron condor, collecting $3.54 ($354 maximum profit, $646 maximum loss), with breakevens at $206.46 and $263.54 and a stated 61% theoretical probability of profit. ServiceNow's Oct. 27 earnings are a potential catalyst because its shares have historically moved in sympathy with Salesforce.

Analysis

The central risk is not routine CRM earnings before expiration; it is a change in the market’s estimate of AI’s net effect on SaaS economics. If AI features lift expansion and retention without compressing seat-based pricing, current skepticism can unwind quickly and CRM can challenge the call side. If customers consolidate seats or defer renewals while testing agents, the same “AI monetization” narrative becomes a multiple headwind even if near-term results remain resilient. Verify paid AI adoption and its contribution to expansion, retention, and guidance rather than treating a strong quarter as proof of durable growth.

The proposed short-volatility exposure is particularly vulnerable to NOW’s October 27 report: a surprise can reprice enterprise-software sentiment and pull CRM outside a range without any CRM-specific news. A 39% implied-volatility reading is not by itself evidence that premium is rich; compare implied move with realized moves, event-adjusted volatility, and downside skew. The reported probability of profit is model-dependent and does not establish positive expected value; the payoff is asymmetric, with capped premium against a materially larger defined loss.

Near term, a range is plausible while investors wait for fresh CRM evidence, but the trade expires before CRM’s December catalyst and therefore cannot monetize resolution of the central debate. Over 6–18 months, differentiation will accrue to vendors that show incremental AI revenue without undermining per-seat economics; weak proof risks sector-wide multiple compression. Falsify the range thesis on a sustained break beyond the short strikes, a sharp post-NOW software-sector repricing, or CRM guidance/adoption evidence that changes expected growth materially.

Key Decisions for Investors

• Do not sell the full iron condor solely because CRM has recently traded sideways. If expressing the range view, use defined-risk, limited sizing and reassess after NOW’s October 27 results; avoid carrying unchanged exposure through a volatility repricing.
• For the cited structure, manage to a pre-set fraction of collected premium rather than waiting for expiration, and reduce or exit if CRM approaches either short strike or if the NOW read-through shifts the software tape. The stated maximum loss is not a practical stop level.
• Monitor CRM’s paid AI adoption, renewal/expansion signals, and forward growth commentary. Improving evidence can favor CRM upside despite valuation uncertainty; signs of seat compression or weaker guidance would invalidate the neutral thesis and increase downside-tail risk.
• Treat 39% implied volatility as a relative-value question, not a sell signal: check event-adjusted implied versus realized volatility and put skew before entry. If premium is not attractive after accounting for the NOW catalyst and gap risk, no trade is preferable.